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Early-onset Parkinson’s disease (EOPD) patients are symptomatic at a relatively young
age, and the impacts of the disease on both the patients and their caregivers are
dramatic. Few studies have reported on the cognitive impairments seen in EOPD, and
the results of these studies have been diverse. Furthermore, it is still unclear what
microstructural white matter (WM) changes are present in EOPD patients. As such, we
conducted this study to investigate the microstructural WM changes experienced by
EOPD patients and their association with cognitive function and plasma DNA levels.
We enrolled 24 EOPD patients and 33 sex- and age-matched healthy volunteers
who underwent complete neuro-psychological testing (NPT) to evaluate their cognitive
function and diffusion tensor imaging (DTI) scanning to determine their fiber integrity.
The plasma DNA measurements included measurements of nuclear and mitochondrial
DNA levels. Fractional anisotropy (FA) maps were compared using voxel-based statistics
to determine differences between the two groups. The differences in DTI indices and
NPT scores were correlated after adjusting for age, sex, and education. Our results
demonstrate that patients with EOPD have elevated nuclear DNA levels and wide
spectrums of impairments in NPT, especially in the executive function and visuospatial
function domains. Exploratory group-wise comparisons of the DTI indices revealed that
the patients with EOPD exhibited lower DTI parameters in several brain locations. These
poorer DTI parameters were associated with worse cognitive performances and elevated
plasma nuclear DNA levels, especially in the anterior thalamic radiation region. Our
findings suggest that the thalamus and its adjacent anterior thalamic radiation may be
important in the pathogenesis of EOPD, as they appear to become involved in the disease
process at an early stage.
Keywords: cognitive impairment, diffusion tensor imaging, early-onset Parkinson’s disease, white matter, plasma
DNA
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INTRODUCTION
Parkinson’s disease (PD) is one of the most common
neurodegenerative diseases worldwide (Aarsland et al., 2009).In
addition to its characteristic motor symptoms, PD is associated
with a spectrum of cognitive dysfunction, ranging from mild
cognitive impairment to dementia (Kehagia et al., 2010).
Although PD mainly affects older patients, with a mean age
of onset at around 60 years old, some patients develop it at a
relatively early age (Schrag et al., 2003). Since these younger
patients are often the wage earners in their families, the cognitive
impairment caused by PD may cause greater impacts on them
and their families than does the cognitive impairment aﬄicting
older onset PD patients. Studies have shown that the cognitive
impairments in PD occur within various domains, including
the attention, executive, memory, language, and visuospatial
domains (Litvan et al., 2012). However, the cognitive function
of patients with early-onset PD (EOPD) is less well-studied,
with only a few studies having reported that EOPD patients may
experience slower disease progression and less overall cognitive
impairment relative to other PD patients (Hietanen and
Teräväinen, 1988; Wickremaratchi et al., 2009). The underlying
pathophysiology for the cognitive impairments seen in EOPD
patients is also yet to be determined.
Diffusion tensor imaging (DTI) is an advanced magnetic
resonance imaging (MRI) technique that has been used to
evaluate the brains of patients affected by various clinical
conditions, including brain tumors, hepatic encephalopathy,
psychiatric disorders, epilepsy, and neurodegenerative disorders
(Chaudhary and Duncan, 2014; Lerner et al., 2014; Lin et al.,
2014a; Teipel et al., 2014; Arat et al., 2015). Studies using DTI
have demonstrated extensivemicrostructural white matter (WM)
damage in PD patients (Karagulle Kendi et al., 2008; Agosta
et al., 2013; Kim et al., 2013). Recent studies have further
established clear associations between the cognitive impairments
of PD patients and their WMmicrostructural changes (Gallagher
et al., 2013; Theilmann et al., 2013; Zheng et al., 2014). DTI can
be used to assess WM microstructural integrity by measuring
the water diffusion characteristics in tissues (Le Bihan, 2003).
As such, analyzing the WM microstructural changes in EOPD
patients may help us understand the pathology of the disease
and further delineate its relationship with the resulting cognitive
impairments.
There is growing evidence that oxidative stress and
neuroinflammation play important roles in the pathogenesis of
PD (More et al., 2013; Tolleson and Fang, 2013; Coppedè and
Migliore, 2015). These insults may then cause neuronal cell death
in the brain (Taylor et al., 2013). Neuron loss in PD is due to
both apoptosis and necrosis (Perier et al., 2012). These processes,
together with the disruption of the blood-brain barrier, may in
Abbreviations: WM, white matter; PD, Parkinson’s disease; EOPD, early-onset
Parkinson’s disease; DTI, diffusion tensor imaging; FA, fractional anisotropy; MD,
mean diffusivity; UPDRS, Unified Parkinson’s Disease Rating Scale; modified
H & Y scale, modified Hoehn and Yahr Staging Scale; S & E scale, Schwab
and England Activities of Daily Living Scale; ANCOVA, analysis of covariance;
WAIS-III,Wechsler Adult Intelligence scale-III; CASI, Cognitive Ability Screening
Instrument.
turn cause free plasma DNA to be detected in peripheral blood
(Martin et al., 1998; Cabezas et al., 2014). Elevated levels of
plasma DNA have been shown to be associated with cell death in
various diseases, including various cancers, traumas, infections,
and vascular events (Wu et al., 2002; Lam et al., 2003; Rainer
et al., 2003; Rhodes et al., 2006; Lu et al., 2010; Arnalich et al.,
2013). However, the presentation and role of plasma DNA in
EOPD patients remains unclear.
The present study aimed to investigate the WM
microstructural integrities, cognitive statuses, and plasma
DNA levels of EOPD patients, as well as to further explore the
associations among them. First, the cognitive statuses, WM
microstructural integrities, and plasma DNA levels of EOPD
patients were compared with those of healthy controls. Second,
the WMmicrostructural differences between EOPD patients and
healthy controls were associated with the differences in cognitive
statuses and plasma DNA levels.
MATERIALS AND METHODS
Participants
Twenty-four patients (9 males and 15 females; mean age:
48.4 ± 6.5 years) younger than 55 years old with idiopathic
PD diagnosed according to the United Kingdom Brain Bank
criteria (Gibb and Lees, 1988) and without other neurological
disorders or psychiatric disease were prospectively enrolled at the
Neurology Department of Chang GungMemorial Hospital. Each
patient’s disease severity and functional status were evaluated
using the Unified Parkinson’s Disease Rating Scale (UPDRS), the
modified Hoehn and Yahr Staging Scale, and the Schwab and
England Activities of Daily Living Scale. The UPDRS score is
the scale most commonly used to follow the longitudinal course
of PD and is evaluated by interview and clinical observation
(Ramaker et al., 2002). The modified Hoehn and Yahr Scale
is a global assessment of the severity of PD based on clinical
findings and functional disability, with stages 1 through 5
indicating increasing levels of disease severity (Zhao et al.,
2010). The Schwab and England Activities of Daily Living
Scale assess the independence of PD patients, with a score
of 100% indicating completely independent function while a
score of 0% indicates bedridden status with only vegetative
function (McRae et al., 2002). Thirty-three sex- and age-matched
healthy subjects (15 males and 18 females; mean age: 48.6 ±
7.8 years) with similar education levels and without neurologic
disease, psychiatric illness, alcohol, or substance abuse, or head
injury were recruited from the hospital as a control group.
Participants with cancer, end-stage renal disease, active infection,
a history of major trauma, autoimmune disease, or any chronic
inflammatory disorder were excluded from both the patient and
control groups. The hospital’s Institutional Review Committee
on Human Research approved the study protocol, and all of
the participants or their guardians provided written informed
consent.
Neuro-Psychological Testing
A clinical psychologist blinded to each patient’s status performed
a neuro-psychological battery of tests focusing on the attention,
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executive, speech, and language, memory, and visuospatial
functions. Attention functions were assessed by the digit span
score from the Wechsler Adult Intelligence scale-III (WAIS-
III) (Kaufman and Lichtenberger, 2006) and by the attention
and orientation score from the Cognitive Ability Screening
Instrument (CASI) (Teng et al., 1994). Executive functions were
assessed using the digit symbol coding, similarity, arithmetic,
picture arrangement, and matrix reasoning scores from the
WAIS-III, as well as the abstract thinking scores from the CASI.
Memory functions were assessed using the short- and long-
term memory scores from the CASI and the information scores
from the WAIS-III. Speech and language ability were assessed
using the vocabulary and comprehension scores from the WAIS-
III and the language score from the CASI. Visuospatial functions
were assessed using the picture completion and block design
scores from the WAIS-III and the drawing score from the CASI.
Diffusion Tensor Imaging
Image Acquisition
The MR data were acquired on a 3.0T whole body GE Signa
MRI system (General Electric Healthcare, Milwaukee, WI, USA).
For each subject, the subject’s head was immobilized with foam
pillows inside the coil to diminish motion artifacts. First, the T1-
weighted structured images were acquired for localization of FA
differences using a 3D-FSPGR sequence (repetition time (TR)
= 9.492ms, echo time (TE) = 3.888ms, flip angle = 20◦, field
of view (FOV) = 24 × 24 cm, matrix size = 512 × 512, 110
continuous slices with a slice thickness of 1.3mm and in-plane
spatial resolution of 0.47 × 0.47mm) through the whole head
parallel to the anterior-posterior commissure (AC-PC).
Then, DTI scans were acquired for whole-brain voxel-wise
analysis of the WM microstructure using a single-shot echo-
planar imaging sequence (TR = 15,800ms, TE = 77ms, number
of excitations (NEX) = 3, matrix size = 128 × 128, field of
view (FOV) = 25.6 cm, voxel size = 2 × 2 × 2.5 mm3, 55
axial oblique slices without gaps). The DTI gradient encoding
schemes included 13 non-collinear directions with a b value of
1000 s/mm2 and a non-diffusion weighted image volume with a
b-value of 0 s/mm2 (null image).
Data Pre-processing
The FA maps for each subject were computed using an
in-house program registered to the ICBM 152 template
(Montreal Neurological Institute). In the first step, a group
template was created by spatially normalizing each T1-weighted
structural MR image to the ICBM 152 template using the
optimum 12-parameter affine transformation. These images were
subsequently averaged and smoothed with an isotropic 8mm
full-width at half maximum Gaussian kernel.
In the second step, non-diffusion weighted (b = 0) images
of an individual subject were co-registered to their T1-weighted
structural images as the cost function based on normalized
mutual information. Thereafter, the registration parameters were
applied on the FA maps that were inherently registered to other
diffusion-weighted images during the acquisition. To remove
non-brain tissue and background noise for these FA maps, the
Brain Extraction Tool (BET) compiled in the FSL library 4.1
(Oxford Centre for Functional Magnetic Resonance Imaging of
the Brain, Oxford University, Oxford, UK) was applied.
In the third step, an affine transformation was applied with a
series of non-linear warps characterized by a linear combination
of three dimension discrete cosine transform (DCT) basis
functions in order to transform all of the 64 T1-weighted scans
to the same stereotactic space as the customized template image.
The transformation parameters derived from this step were also
applied to the FA maps, which were then effectively registered to
the MNI space.
Laboratory Measurement of Plasma DNA
in the Peripheral Circulation
Plasma levels of nuclear and mitochondrial DNA were assessed
in both the patient and control groups. Blood was drawn by
venipuncture from the forearm on the same day as theMRI study
and the neuro-psychological testing.
In every patient, 3ml of peripheral venous blood was
collected into ethylenediaminetetraacetic acid–containing tubes.
The blood samples were centrifuged for 10 min at 3000 rpm
and then transferred to another 1.5ml polypropylene tube for
another centrifugation for 10 min at 10,000 rpm. The plasma
samples were frozen at−20◦C prior to extraction. The DNA was
then extracted from the plasma samples using a QIAamp Blood
Kit (Qiagen, Hilden, Germany) according to the manufacturer’s
protocol.
The plasma DNA was measured by a real-time quantitative
polymerase chain reaction (RT-PCR) assay (Roche LightCycler,
Roche, Grenzach-Wyhlen, Germany) for the β-globin gene
(present in all nucleated cells) and ND2 genes (specific for
mitochondrial DNA). Quantitative results were expressed as
ng/ml. Procedural details were described in a previous study
(Wang et al., 2013).
Statistical Analysis
Analysis of Demographic Data
The demographic data, including the age and sex data, were
compared among the study groups using the 2-sample Student
t-test and Pearson chi-square test, where appropriate, and
were reported as mean ± the standard deviation (SD). The
significance of differences in Mini-Mental State Examination
(MMSE), disease severity, and neuropsychological test scores
were analyzed by analysis of covariance (ANCOVA), with the
participant’s age, sex, and education level as covariates. The
plasma DNA levels were compared by Mann-Whitney U-test.
Group Comparison of FA Values between Patients
and Controls
Voxel-wise group comparisons were conducted using the
SPM8 (Statistical Parametric Mapping; http://www.fil.ion.ucl.ac.
uk/spm/; University College London, London, UK) software
package in Matlab R2010a (Mathworks, Natick, MA, USA). After
normalization and smoothing of the FA images, analysis was
performed with SPM8 using the general linear model. ANCOVA
was then performed with age and sex as covariates to detect
FA differences between the groups. The probability threshold
was set at 0.2 to exclude voxels with a substantial probability
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of containing gray matter or cerebrospinal fluid. The statistical
threshold was set at an uncorrected P < 0.005, with a cluster of
>100 contiguous voxels.
The FSL atlas tool (http://www.fmrib.ox.ac.uk/fsl/fslwiki/
Atlases) was applied for determining the most probable fiber
tracts and anatomic location of each significant cluster.
Region of interest (ROI) analyses were used to determine the
mean FA value of each significantly different cluster. The ROI
masks were extracted using the Marsbar toolbox (http://marsbar.
sourceforge.net/download.html). The mean diffusivity values of
these areas were compared between groups by multivariate
analysis of covariance, with age and sex as covariates. Significance
was set at a Bonferroni corrected P < 0.05.
Correlations among Disease Duration,
Neuro-Psychological Assessment Scores,
DTI-Related Indices, and Plasma DNA Levels
Partial correlation analysis was performed with age and sex
adjustments to determine the associations between DTI changes
and plasma DNA levels and disease duration. Partial correlation
analysis for assessment of the associations between DTI changes
and cognitive functions was performed after controlling for age,
sex, and education. The threshold for all statistical significance
was set at P < 0.05. SPSS software (SPSS V.17, Chicago, IL, USA)
was used to perform all the statistical analyses.
RESULTS
Baseline Clinical Characteristics of EOPD
Patients and Controls
The baseline clinical demographics and neuro-psychological
assessment scores of all the subjects are listed in Table 1.
Statistical analysis of the clinical demographics showed no
significant difference between the two groups. The patients with
EOPD performed poorly on the neuro-psychological assessments
of executive function [digit symbol coding (p= 0.001), arithmetic
(p = 0.001), matrix reasoning (p = 0.028)] and visuospatial
function [picture completion (p = 0.031), block design (p =
0.001), drawing (p = 0.007)]. Higher plasma nuclear DNA levels
were also observed in the EOPD patients (Figure 1).
Group Comparisons on FA Maps
The EOPD patients had significantly lower FA values in several
WM regions than the control group. Together with these
lower FA values, there were WM regions with increased mean
diffusivity (MD) values in the left inferior parietal WM, bilateral
occipital WM, right parietal WM, and right posterior superior
longitudinal fasciculus (Table 2; Figure 2).
Correlations between Disease Duration
and Regional DTI-Related Indices and
Plasma DNA Levels
There were no significant correlations between disease duration
and DTI signal changes or plasma DNA levels.
TABLE 1 | Demographic data and neuro-psychological assessment data
of patients with EOPD and controls.
Clinical demographics PD (n = 24) Control (n = 33) P-value
Age (year) 48.4 ± 6.5 48.6 ± 7.8 0.911
Sex (M, F) 9, 15 15, 18 0.548
Disease duration (year) 3.23 ± 3.05
UPDRS I 3.00 ± 2.54
UPDRS II 7.52 ± 5.85
UPDRS III 19.09 ± 13.63
UPDRS total 29.52 ± 20.66
Modified H & Y 1.74 ± 1.00
S & E 88.26 ± 13.37
MMSE 27.38 ± 2.37 28.26 ± 1.83 0.096
NEURO-PSYCHOLOGICAL ASSESSMENTS
Attention Function
Digit span 10.35 ± 3.34 11.22 ± 2.24 0.258
Attention 7.70 ± 0.56 7.44 ± 0.91 0.168
Orientation 17.48 ± 1.56 17.78 ± 0.71 0.386
Executive Function
Digit symbol coding 8.26 ± 3.00 10.56 ± 2.40 0.001*
Similarity 9.74 ± 3.37 9.94 ± 2.03 0.726
Arithmetic 8.22 ± 2.52 10.69 ± 2.06 0.001*
Picture arrangement 9.44 ± 2.64 10.50 ± 2.48 0.189
Matrix reasoning 8.83 ± 3.68 10.91 ± 2.82 0.028*
Abstract thinking 10.09 ± 1.65 10.16 ± 1.39 0.821
Memory Function
Short-term memory 10.47 ± 1.80 10.04 ± 2.04 0.268
Long-term memory 9.91 ± 0.42 10.00 ± 0.00 0.330
Information 9.09 ± 2.31 9.81 ± 2.56 0.523
Speech and Language
Vocabulary 9.70 ± 3.59 10.63 ± 3.02 0.057
Comprehension 9.30 ± 3.01 9.78 ± 3.05 0.912
Language 9.79 ± 0.42 9.88 ± 0.44 0.648
Visuospatial Function
Picture completion 8.48 ± 2.83 10.72 ± 3.74 0.031*
Block design 8.22 ± 2.73 10.53 ± 2.38 0.001*
Drawing 9.44 ± 1.08 10.00 ± 0.00 0.007*
UPDRS, Unified Parkinson’s Disease Rating Scale; Modified H & Y, Modified Hoehn and
Yahr stages; S & E, Schwab and England activities of daily living scale; MMSE, Mini Mental
State Examination.
Sex data were compared by Pearson chi-square test. Age data were compared by
independent t-test. MMSE and neuro-psychological assessment data were compared
by analysis of covariance (ANCOVA) after controlling for age, sex, and education.
Data are presented as mean ± standard deviation. *p < 0.05.
Correlations between Regional
DTI-Related Indices and
Neuro-Psychological Assessment Scores
There were significant correlations between worse visuospatial
function (drawing) scores and increased MD values of
the left anterior thalamic radiation and decreased FA
values of the left superior parietal WM. Furthermore,
worse executive function (arithmetic) was associated with
increased MD values of the right anterior thalamic radiation
(Table 3).
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Correlations between Regional
DTI-Related Indices and Plasma DNA
Levels
There were significant correlations between increased nuclear
DNA levels and decreased FA values of the left corticospinal
tract and right anterior thalamic radiation, as well as increased
FIGURE 1 | Quantitative analysis of plasma nuclear and mitochondrial
DNA levels in an EOPD patient group (n = 24) in comparison with a
healthy control group (n = 33). The plasma nuclear DNA levels were
significantly increased (P < 0.05) in the EOPD patients; the plasma
mitochondrial DNA levels showed no significant difference.
MD values of the bilateral occipital WM and right parietal WM
(Table 3).
DISCUSSION
In this study, we found that EOPD patients have higher
plasma nuclear DNA levels and greater cognitive impairments
in the executive and visuospatial function domains than healthy
individuals, as well as extensive WM microstructural changes as
indicated by decreased FA or increased MD values. These WM
microstructural changes were associated with elevated plasma
DNA levels and cognitive impairments in the executive and
visuospatial domains.
PD may cause more substantial psychosocial and
socioeconomic impacts on younger patients. They may
experience early unemployment, poor quality of life, depression,
and marital discord (Schrag et al., 2003). Furthermore, the
disease also places burdens on a patient’s spouse and children
(Carter et al., 1998; Schrag et al., 2004). In this study, we focused
on relatively young PD patients who experienced disease onset
before 55 years of age. Although this cutoff of 55 years of
age is somewhat higher than that traditionally used to define
EOPD, our patients, with a mean age of <50 years old, were still
relatively young in comparison to patients with regular PD, such
that many are still working and may also have young children to
raise. As such, the motor symptoms and cognitive impairment
TABLE 2 | Regions showing fractional anisotropy differences among patients with PD and control subjects.
MNI atlas coordinates FA, mean (SD) Diffusivity Values
(PD-NC)
(x10−6mm2/s)
x y z Voxel size White matter tract Nearest cortical area Controls PD Tmax MD
DECREASED FA IN PD vs. CONTROLS
30 38 21 320 Right anterior superior
longitudinal fasciculus
Right frontal lobe 0.294 (0.049) 0.263 (0.058) 4.19 −0.394
55 −34 13 293 Right temporal WM Right temporal lobe 0.348 (0.038) 0.310 (0.036) 4 −6.277
−27 −63 28 920 Left inferior parietal WM Left parietal lobe 0.424 (0.040) 0.386 (0.027) 3.82 34.348*
−18 59 −3 435 Left anterior thalamic
radiation
Left frontal lobe 0.329 (0.033) 0.305 (0.019) 3.61 17.511
−15 −59 24 140 Left occipital WM Left occipital lobe 0.298 (0.048) 0.260 (0.038) 3.53 28.667*
49 −25 23 109 Right pariental WM Right parietal lobe 0.271 (0.047) 0.231 (0.066) 3.39 71.144*
39 −58 23 100 Right posterior superior
longitudinal fasciculus
Right temporal lobe 0.369 (0.065) 0.314 (0.048) 3.39 39.292*
−29 −75 14 422 Left inferior fronto-occipital
fasciculus
Left occipital lobe 0.602 (0.046) 0.562 (0.038) 3.35 23.057
−23 −19 54 575 Left corticospinal tract Left frontal lobe 0.569 (0.037) 0.539 (0.038) 3.29 14.837
13 −58 24 252 Right occipital WM Right occipital Lobe 0.327 (0.046) 0.286 (0.050) 3.28 59.337*
−22 0 −3 219 Left putamen Left lentiform nucleus 0.252 (0.031) 0.229 (0.016) 3.27 1.852
7 −13 1 841 Right anterior thalamic
radiation
Right thalamus 0.334 (0.019) 0.316 (0.018) 3.08 26.606
−31 −34 54 122 Left superior pariental WM Left parietal lobe 0.564 (0.053) 0.491 (0.060) 2.99 25.898
Location of maximum effect (uncorrected P < 0.005, cluster size > 100) was shown in the Montreal Neurological Institute (MNI) space. Group FA mean values in each cluster are
presented as mean ± standard deviation.
The FA and MD values in region of interest were further compared between two groups by analysis of covariance after controlling for age and sex. * P < 0.05 with a Bonferroni correction,
accounting for multiple ROI comparisons. WM, white matter; FA, fractional anisotropy; MD, mean diffusivity; PD, Parkinson’s disease; NC, Normal Controls.
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FIGURE 2 | Comparison of fractional anisotropy (FA) values between EOPD patients and healthy controls. There were diffuse diffusion tensor imaging (DTI)
deficits in the EOPD group as compared with the healthy control group. Orange voxels indicated regions with significantly lower FA values in the EOPD patients vs. the
healthy controls (p < 0.005, uncorrected).
TABLE 3 | Correlations among diffusion tensor imaging (DTI)
abnormalities, cognitive function, and plasma DNA levels.
Anatomy DTI Poor NPT (r,p) ↑Plasma DNA(r,p)
Left anterior
thalamic radiation
↑MD Drawing (−0.857,
0.015)
Left occipital WM ↑MD Nuclear DNA (0.307, 0.028)
Right parietal WM ↑MD Nuclear DNA (0.352, 0.011)
Left corticospinal
Tract
↓FA Nuclear DNA (−0.284, 0.043)
Right occipital WM ↑MD Nuclear DNA (0.343, 0.014)
Right anterior
thalamic radiation
↓FA Nuclear DNA (−0.349, 0.012)
↑MD Arithmetic (−0.878,
0.009)
Left superior
parietal WM
↓FA Drawing (0.780,
0.038)
Correlations among diffusion tensor abnormalities and neuro-psychological test (NPT)
scores were performed by partial correlation after controlling for age, sex, and education.
Correlations between diffusion tensor abnormalities and plasma DNA levels were
performed by partial correlation after controlling for age and sex. * P < 0.05 with
a Bonferroni correction, accounting for multiple region of interest comparisons. FA,
fractional anisotropy; MD, mean diffusivity; WM, white matter.
resulting from their EOPD may cause greater impacts on these
patients.
The cognitive impairment seen in PD patients is well-
documented. PD patients exhibit frontal-executive cognitive
impairments similar to those of patients with frontal lobe
lesions (Kehagia et al., 2010). While the cognitive impairments
in PD patients may involve the attention, executive, memory,
visuospatial, and language domains, the most commonly
impaired domain is memory (Aarsland et al., 2010). The
cognitive impairment seen in EOPD patients is less well-studied.
Among the available studies, some have reported no significant
cognitive impairments in EOPD patients (Schrag and Schott,
2006; Wickremaratchi et al., 2009; Caccappolo et al., 2011),
while others have reported that EOPD patients may have some
cognitive impairments (Hietanen and Teräväinen, 1988; Dubois
et al., 1990; Tsai et al., 1994). The discrepancies between the
existing studies may be due to differences in the ages and disease
severities of the patients investigated, as well as differences in
the neuropsychological testing methods applied. In this study,
we performed comprehensive neuropsychological assessments of
EOPD patients who were in relatively early stages of the disease
in terms of disease severity. We found significant cognitive
impairments in the executive and visuospatial domains. These
results may imply underlying brain structural changes in EOPD
patients.
DTI is an advanced MRI technique that can assess brain
microstructures noninvasively by measuring both the direction
and magnitude of water molecule diffusion. The most commonly
used parameters in DTI are FA and MD. FA measures the
proportion of directionality of water diffusion and therefore
reflects the integrity of the myelination and organization of axon
fibers (Laule et al., 2007; Johansen-Berg and Rushworth, 2009).
MD measures the quantity of overall diffusion in a given voxel
regardless of its direction and therefore reflects the overall density
or integrity ofWMfibers (Burzynska et al., 2010; Rae et al., 2012).
To the best of our knowledge, we are the first group to report
WM microstructural changes using DTI in EOPD patients.
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Previous DTI studies of PD patients have shown extensive
WM microstructural changes, albeit with a diversity of results,
with most studies reporting WM changes in the frontal lobe
(Cochrane and Ebmeier, 2013; Kim et al., 2013). Similar to the
results previously found for PD patients, we found extensive
WM microstructural changes, as indicated by a decrease in FA
values or an increase inMD values, involving the frontal, parietal,
temporal, and occipital lobes in the EOPD patients. These
changes may be related to the pathological mechanisms of EOPD.
Among the brain regions with significant DTI changes identified
in this study, an isolated decrease in FA values was identified
mostly in the frontal lobe and nearby deep gray matter, which
may reflect underlying demyelination in these brain regions in
EOPD patients. Decreased FA values along with increased MD
values were identified mostly in the parietal and occipital lobes,
which may reflect gliosis or axonal loss in these brain regions in
EOPD patients.
Cognitive function is associated with cortical atrophy in
PD patients, such that PD patients with cognitive impairments
may show more extensive cortical atrophy and decreased
cortical perfusion compared with PD patients without cognitive
impairments (Ibarretxe-Bilbao et al., 2009; Chen et al., 2016;
Lin et al., 2016) Relatedly, in PD patients with dementia, a
previous study reported extensive frontal and subcortical atrophy
compared with PD patients with no cognitive impairment
(Borroni et al., 2015). The results of this study, meanwhile,
show extensive WM changes even in the early stages of the
disease. Future studies with voxel-based morphometry analysis
in combination with DTI analysis may further clarify the
relationship between gray matter atrophy and WM changes in
EOPD patients.
Plasma DNA levels can become elevated due to various insults
causing cell death with subsequent release of DNA into the
circulating plasma. Recent studies have also found increased
plasma nuclear DNA levels in chronic neurodegeneration
disorders like Friedreich’s ataxia and spinocerebellar ataxia
(Swarup et al., 2011). In PD, oxidative stress is an important
contributing factor in the development of the disease. Elevated
oxidative stress, along with neuroinflammation, leads to neural
cell damage and death (Hald and Lotharius, 2005; Chen et al.,
2015). This neuron death, accompanied by the breakdown of
the blood-brain barrier, causes the release of DNA into the
plasma. Furthermore, since PD patients have increased systemic
inflammation and peripheral cell death that are correlated with
disease severity, increased cell death with the release of DNA
into the plasma may occur (Lin et al., 2014b, 2015; Macchi
et al., 2015; Yu et al., 2016). Either way, the levels of plasma
nuclear DNAmay rise. In this study, we found increased levels of
plasma nuclear DNA in the EOPD patient group. We also found
significant associations between elevated plasma nuclear DNA
levels and WM microstructural changes. This finding supports
the notion that EOPD patients may exhibit increased oxidative
stress with possible associated neural damage and death that lead,
in turn, to extensiveWMmicrostructural changes visible via DTI.
However, further longitudinal studies are needed to delineate
the causal relationships between the elevated oxidative stress and
WM changes in EOPD patients.
The results of this study also indicated associations between
executive function impairment andWMmicrostructural changes
in the anterior thalamic radiation, a finding which is similar to
that of a previous study conducted on PD patients (Zheng et al.,
2014). This WM region, which is adjacent to the thalamus, is also
associated with elevated plasma nuclear DNA levels. According
to the Braak staging, pathology in the PD brain spreads from the
dorsal nucleus of the vagus nerve (stage I) to the brain stem in
an ascending fashion from the medulla (stage II) to the midbrain
(stage III) to the mesocortex, basal forebrain, and thalamus (stage
IV) and then to the neocortex (stages V and VI) (Braak et al.,
2003). It is not until after stage III that patients may start to
present with motor symptoms (Dexter and Jenner, 2013). Since
the patients in this study were still in the relatively early stages
of the disease (with the mean modified Hoehn and Yahr Stage
scores of <2), our results implied that the thalamus may be an
important region in the pathogenesis of EOPD, and that it is
affected early in the disease process. This finding is compatible
with the notion that the executive function impairments in PD
are due to alterations in the corticostriatal pathway (Albin et al.,
1989; Chou et al., 2015). Recently, functional MRI studies have
demonstrated that the executive function impairments in PD are
mediated not only by alterations in the corticostriatal pathway
but also the mesolimbic pathway (Monchi et al., 2004, 2007;
Au et al., 2012). Future studies with functional MRI focusing
on specific types of executive function assessment may further
delineate the complex relationships between the brain activation
pathways and executive impairments in EOPD patients.
Limitations
This study does have several limitations. First, the patients who
participated were recruited from a single tertiary center and so
may not be representative of all EOPD populations. Second, due
to the relatively small sample of patients, the association analysis
in this study only included items for which the EOPD patients
scored significantly poorer than the control group. Third, this
study was a cross-sectional study and, as such, readers should
interpret the results with caution. Further causal relationships
among DTI changes, cognitive function changes, and plasma
DNA levels may thus need to be delineated by future longitudinal
studies. Lastly, although DTI indices such as FA and MD are
sensitive markers for detecting brain microstructural changes,
they lack specificity (Pierpaoli and Basser, 1996). Using newer
diffusion MR technologies such as neurite orientation dispersion
and density imaging (NODDI), which separates diffusion in the
brain into intraneurite, extraneurite, and CSF compartments,
may increase the specificity for identifying WM microstructural
changes (Zhang et al., 2012).
CONCLUSION
In this study we found extensive WM damage and elevated
systemic oxidative stress in EOPD patients. Our findings support
the notion that thalamus and its adjacent anterior thalamic
radiation may be important in the pathogenesis of EOPD, as it
appears to become involved in the disease process at an early
stage. A longitudinal study may further delineate the causal
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relationships among the cognitive impairment, DTI changes, and
plasma DNA level alterations found in EOPD patients.
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